Home https://server7.kproxy.com/servlet/redirect.srv/sruj/smyrwpoii/p2/ Business https://server7.kproxy.com/servlet/redirect.srv/sruj/smyrwpoii/p2/ Novavax’s stock increased after announcing a vaccine deal with Endo

Novavax’s stock increased after announcing a vaccine deal with Endo



Shares of Novavax Inc. NVAX,
+ 5.62%
jumped 6.8% in preliminary trading on Friday after the company announced a deal to produce vaccines COVID-19 with Endo International ENDP,
+ 10.92%.
Shares of Endo rose 7.3%. One of Endo’s subsidiaries will provide coating services at a factory in Rochester, Michigan; the product being produced is expected to be used in the company̵

7;s Phase 3 for NVX-CoV2373 in the United States, as well as for potential general distribution to the public if the vaccine applicant receives some type of regulatory approval or authorization. Novavax CEO Stanley Erk said in a news release that the company was preparing for its major Phase 3 clinical trial in the United States, “to begin very soon.” clinical trials in the UK. So far this year, Novavax shares have risen by 2,473.9%, Endo shares have fallen by 35.6% and the S&P 500 SPX,
-0.17%
is 0.5%.


Source link